CALCULATING DRUG DOSAGES:
v v
A Patient-Safe Approach to Nursing and Math
v v v v v v
2nd Edition
v
Castillo | Werner-McCullough
v v
TESTBANK v
,Castillo/Werner-McCullough:vCalculatingvDrugvDosages:vAvPatient-SafevApproachvtovNursingvandvMath,,2ev TestvBank
TablevofvContents:
I. SafetyvinvMedicationvAdministrationv Chapterv1.v
SafetyvinvMedicationvAdministrationv Chapterv2.vThevD
rugvLabel
II. SystemsvofvMeasurementv Chapt
erv3.vThevMetricvSystemv Chapterv4.vTh
evHouseholdvSystem
III. MethodsvofvCalculation
Chapterv5.vLinearvRatiovandvProportionv Chapterv6.vF
ractionalvRatiovandvProportionv Chapterv7.vDimensio
nalvAnalysis
Chapterv8.vFormulavMethod
IV. AdministrationvofvMedications
Chapterv9.vCalculatingvOralvMedicationvDosesv Chapt
erv10.vSyringesvandvNeedles
Chapterv11.vCalculatingvParenteralvMedicationvDosagesv Chapt
erv12.vPreparingvPowderedvParenteralvMedicationsv Chapterv13
.vAdministrationvofvInsulin
V. IVvTherapyvandvAdministrationvofvIntravenousvMedications
Chapterv14.vIntravenousvInfusionvandvInfusionvRatesv Chapterv15.v
CalculatingvInfusionvandvCompletionvTimev Chapterv16.vAdminister
ingvIVvPushvMedications
VI. VerifyingvSafevDosevandvCriticalvCarevCalculations
Chapterv17.vVerifyingvSafevDose
Chapterv18.vTitrationvofvIntravenousvMedications
VII. IntakevandvOutput
Chapterv19.vCalculatingvIntakevandvOutputv Chapterv2
0.vCalculatingvParenteralvIntake
VIII. DosagesvforvPediatricvandvOldervAdultvPopulations
Chapterv21.vConsiderationsvforvthevPediatricvPatientv Chapterv22.v
ConsiderationsvforvthevOldervAdult
,Castillo/Werner-McCullough:vCalculatingvDrugvDosages,v2e
Chapterv1:vSafetyvinvMedicationvAdministration
Castillo:vCalculatingvDrugvDosages:vAvPatient-SafevApproachvtovNursingvandvMathv2ndvEdition
MULTIPLEvCHOICE
1. Thevfollowingvmedicationvordervisvinvthevpatient’svmedicationvadministrationvrecordv(MAR):
methylPREDnisolonev40vmgvPOvdailyvatv0900.
Aftervreadingvthevorder,vthevnursevcorrectlyvdetermines:v A
“PO”visvanvinappropriatevabbreviation.
B thevmedicationvordervisvwrittenvcorrectly.v C
40vmgvshouldvbevwrittenvasv40mg.
D tallvmanvletteringvindicatesvthatvthevdrugvisvavnarcotic.
ANS:vB
Feedback
Thevmedicationvordervhasvallvthevrequiredvcomponentsv(drugvname,vdose,vroute,vandv frequency
vofvadministration)vforvavdrugvorder.v“PO”visvanvappropriatevabbreviation;v 40vmgvisvwrittenvcorrect
lyvwithvavspacevbetweenvthevdosevandvthevunitvofv measurement.vTallvmanvletteringvisvusedvtovdis
tinguishvthevdrugvfromvanothervdrugv withvavsimilarvname.
2. Whichvofvthevfollowingvaccuratelyvdescribesvthev“BoxedvWarning”vfoundvonvavdrugvlabel?v A
Itvisvprimarilyvisvusedvtovidentifyvthevsafevdosevforvthevpatient.
B Itvisvcommonlyvfoundvonvallvdrugvlabels.
C Itvidentifiesvseriousvpotentialvrisksvandvsideveffectsvrelatedvtovdrugvuse.v D
Itvprotectsvthevpatientvbyvprovidingvinformationvtovdecreasevsideveffects.
ANS:vC
Feedback
Avdrugvlabelvwithvavboxedvwarningvprovidesvinformationvtovhealthcarevprofessionalsv andvpatient
svregardingvthevseriousvrisksvandvsideveffectsvrelatedvtovthevdrug.vThev BoxedvWarningvisvnotvthev
primaryvsourcevforvidentifyingvthevpatient’svdrugvdosage.v Thevwarningvisvfoundvonvspecificvpresc
riptionvmedicationsvandvdoesvnotvprovidev informationvtovreducevorvdecreasevsideveffects.
3. Whenvpracticingvsafetyvinvthevadministrationvofvmedication,vforvwhichvofvthevfollowingv medicationvo
rdersvshouldvavnursevseekvclarificationvbeforevthevadministrationvofvthev medication?
1
, Castillo/Werner-McCullough:vCalculatingvDrugvDosages,v2e
A Regularvinsulinv5vuvsubcutvnow.
B Enoxaparinv80vmgvsubcutveveryv12vhours.
C Benadrylv50vmgvPOvPRNveveryv6vhrvforvitching.v D
Ondansetronv4vmgvIVPvstat.
ANS:vA
Feedback
Thev“u”vshouldvnevervbevusedvinvavmedicationvorder;vrather,vforvsafety,vthevwordv “units”vshoul
dvbevspelledvout.vThevothervanswervoptionsvcontainvthevrequiredv componentsvneededvtovsaf
elyvcarryvoutvthevmedicationvorder.
4. Avnursevisvreviewingvavdrugvlabelvwithvavdrugvnamevwrittenvwithvtallvmanvlettering.vWhichv statementsvsho
wsvthevnursevhasvavcorrectvunderstandingvofvtallvmanvletteringvonvavdrugvlabel?v A
“Thevtallvmanvletteringvmeansvthisvisvavhighvalertvdrug.”
B “Thevtallvmanvletteringvhelpsvmevdistinguishvthisvdrugvwithvothervdrugsvthatv havevsimil
arvnames.”
C “ThevtallvmanvletteringvmeansvthatvthisvdrugvmustvhavevavBoxedvWarning.”
D “Thevtallvmanvletteringvhelpsvmevquicklyvidentifyvthatvthisvdrugvisvanvinjectablev drug.”
ANS:vB
Feedback
Tallvmanvletteringvhighlightsvavportionvofvthevdrugvnamevtovhelpvdistinguishvfromv similarvdrugv
names.vItvisvnotvusedvtovidentifyvhighvalertvdrugs,vhighlightvavboxedv warning,vorvidentifyvinject
ablevdrugs.
5. Thevfollowingvmedicationvordersvarevfoundvinvthevpatient’svMAR:
MetforminvHClv500vmgvPOvdailyvatv0900.v Hydrochlorothiazidev25vmgv
POveveryv12vhrvatv0900vandv2100.v Digoxinv.25vmgvPOvdailyvatv0900.
Invreadingvthevmedicationvordersvforvthev0700–
1500vshift,vthevnursevdeterminesvthatvwhichvofv thevfollowingvisvthevpriorityvnursingvintervention?
A ClarifyvthevmetforminvHClvorder.
B Clarifyvthevhydrochlorothiazidevorder.v C
Clarifyvthevdigoxinvorder.
D
Preparevtovadministervthev0900vmedications.v AN
S:vC
2